82_FR_53154 82 FR 52935 - Center for Substance Abuse Prevention; Notice of Meeting

82 FR 52935 - Center for Substance Abuse Prevention; Notice of Meeting

DEPARTMENT OF HEALTH AND HUMAN SERVICES
Substance Abuse and Mental Health Services Administration

Federal Register Volume 82, Issue 219 (November 15, 2017)

Page Range52935-52935
FR Document2017-24717

Federal Register, Volume 82 Issue 219 (Wednesday, November 15, 2017) 
[Federal Register Volume 82, Number 219 (Wednesday, November 15, 2017)]
[Notices]
[Page 52935]
From the Federal Register Online  [www.thefederalregister.org]
[FR Doc No: 2017-24717]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Substance Abuse and Mental Health Services Administration


Center for Substance Abuse Prevention; Notice of Meeting

    Pursuant to Public Law 92-463, notice is hereby given that the 
Substance Abuse and Mental Health Services Administration's (SAMHSA) 
Center for Substance Abuse Prevention (CSAP) Drug Testing Advisory 
Board (DTAB) will meet via web conference on December 6, 2017.
    The board will meet in closed session on December 6, 2017, from 
10:00 a.m. to 4:00 p.m. EST to discuss proposed revisions to the 
Mandatory Guidelines for Federal Workplace Drug Testing Programs (Oral 
Fluid), evaluation of hair as an alternate matrix for drug testing, and 
future board activities. The meeting will be closed to the public as 
determined by the Assistant Secretary for Mental Health and Substance 
Use, SAMHSA, in accordance with 5 U.S.C. 552b(c)(4) and (9)(B), and 5 
U.S.C. App. 2, Section 10(d).
    The web conference call-in number and access code will only be 
available to board members, invited guests, and CSAP staff. 
Registration will be available for members and invited guests online at 
http://snacregister.samhsa.gov/MeetingList.aspx.
    Meeting information and a roster of DTAB members may be obtained by 
accessing the SAMHSA Advisory Committees Web site, http://www.samhsa.gov/about-us/advisory-councils/drug-testing-advisory-board-dtab or by contacting the Designated Federal Officer, Brian Makela.
    Committee Name: Substance Abuse and Mental Health Services 
Administration's Center for Substance Abuse Prevention Drug Testing 
Advisory Board.
    Dates/Time/Type: December 6, 2017, from 10:00 a.m. to 4:00 p.m., 
EST: CLOSED.
    Place: Parklawn Building, 5600 Fishers Lane, Rockville, Maryland 
20857.
    Contact: Brian Makela, Division of Workplace Programs, 5600 Fishers 
Lane, Room 16N02B, Rockville, Maryland 20857, Telephone: 240-276-2600, 
Email: [email protected].

Brian Makela,
Chemist, Substance Abuse and Mental Health Services Administration.
[FR Doc. 2017-24717 Filed 11-14-17; 8:45 am]
 BILLING CODE 4162-20-P

Federal Register / Vol. 82, No. 219 / Wednesday, November 15, 2017 / Notices 52935 Terry S. Clark, Place: National Institutes of Health, 6701 to board members, invited guests, and Asst Information Collection Clearance Rockledge Drive, Bethesda, MD 20892, CSAP staff. Registration will be Officer. (Telephone Conference Call). available for members and invited Contact Person: George Vogler, Ph.D., [FR Doc. 2017–24671 Filed 11–14–17; 8:45 am] guests online at http:// Scientific Review Officer, Center for BILLING CODE 4150–04–P Scientific Review, National Institutes of snacregister.samhsa.gov/ Health, 6701 Rockledge Drive, Room 3140, MeetingList.aspx. MSC 7770, Bethesda, MD 20892, (301) 237– Meeting information and a roster of DEPARTMENT OF HEALTH AND 2693, voglergp@csr.nih.gov. DTAB members may be obtained by HUMAN SERVICES Name of Committee: Center for Scientific accessing the SAMHSA Advisory Review Special Emphasis Panel; Member Committees Web site, http:// National Institutes of Health Conflict: Pain Mechanisms. www.samhsa.gov/about-us/advisory- Date: December 12–13, 2017. councils/drug-testing-advisory-board- Center for Scientific Review; Notice of Time: 8:00 a.m. to 6:00 p.m. dtab or by contacting the Designated Closed Meetings Agenda: To review and evaluate grant applications. Federal Officer, Brian Makela. Pursuant to section 10(d) of the Place: National Institutes of Health, 6701 Committee Name: Substance Abuse Federal Advisory Committee Act, as Rockledge Drive, Bethesda, MD 20892 and Mental Health Services amended, notice is hereby given of the (Virtual Meeting). Administration’s Center for Substance following meetings. Contact Person: John Bishop, Ph.D., Abuse Prevention Drug Testing Scientific Review Officer, Center for Advisory Board. The meetings will be closed to the Scientific Review, National Institutes of public in accordance with the Dates/Time/Type: December 6, 2017, Health, 6701 Rockledge Drive, Room 5182, from 10:00 a.m. to 4:00 p.m., EST: provisions set forth in sections MSC 7844, Bethesda, MD 20892, (301) 408– 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., CLOSED. 9664, bishopj@csr.nih.gov as amended. The grant applications and (Catalogue of Federal Domestic Assistance Place: Parklawn Building, 5600 the discussions could disclose Program Nos. 93.306, Comparative Medicine; Fishers Lane, Rockville, Maryland confidential trade secrets or commercial 93.333, Clinical Research, 93.306, 93.333, 20857. property such as patentable material, 93.337, 93.393–93.396, 93.837–93.844, Contact: Brian Makela, Division of 93.846-93.878, 93.892, 93.893, National Workplace Programs, 5600 Fishers Lane, and personal information concerning Institutes of Health, HHS). individuals associated with the grant Room 16N02B, Rockville, Maryland applications, the disclosure of which Dated: November 8, 2017. 20857, Telephone: 240–276–2600, would constitute a clearly unwarranted David Clary, Email: brian.makela@samhsa.hhs.gov. invasion of personal privacy. Program Analyst, Office of Federal Advisory Brian Makela, Committee Policy. Name of Committee: Center for Scientific Chemist, Substance Abuse and Mental Health Review Special Emphasis Panel; Member [FR Doc. 2017–24685 Filed 11–14–17; 8:45 am] Services Administration. conflict: Auditory Neuroscience. BILLING CODE 4140–01–P [FR Doc. 2017–24717 Filed 11–14–17; 8:45 am] Date: December 5–6, 2017. BILLING CODE 4162–20–P Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant DEPARTMENT OF HEALTH AND applications. HUMAN SERVICES Place: National Institutes of Health, 6701 DEPARTMENT OF HOMELAND Rockledge Drive, Bethesda, MD 20892 Substance Abuse and Mental Health SECURITY (Virtual Meeting). Services Administration Contact Person: John Bishop, Ph.D., U.S. Customs and Border Protection Scientific Review Officer, Center for Center for Substance Abuse Scientific Review, National Institutes of Prevention; Notice of Meeting [1651–0114] Health, 6701 Rockledge Drive, Room 5182, MSC 7844, Bethesda, MD 20892, (301) 408– Pursuant to Public Law 92–463, Agency Information Collection 9664, bishopj@csr.nih.gov. notice is hereby given that the Activities: Crewman’s Landing Permit Name of Committee: Center for Scientific Substance Abuse and Mental Health Review Special Emphasis Panel; AREA: Services Administration’s (SAMHSA) AGENCY: U.S. Customs and Border Oncological Sciences. Center for Substance Abuse Prevention Protection (CBP), Department of Date: December 7, 2017. (CSAP) Drug Testing Advisory Board Homeland Security. Time: 8:00 a.m. to 5:00 p.m. ACTION: 60-Day Notice and request for Agenda: To review and evaluate grant (DTAB) will meet via web conference on applications. December 6, 2017. comments; extension of an existing Place: National Institutes of Health, 6701 The board will meet in closed session collection of information. Rockledge Drive, Bethesda, MD 20892. on December 6, 2017, from 10:00 a.m. to Contact Person: Svetlana Kotliarova, Ph.D., 4:00 p.m. EST to discuss proposed SUMMARY: The Department of Homeland Scientific Review Officer, Center for revisions to the Mandatory Guidelines Security, U.S. Customs and Border Scientific Review, National Institutes of for Federal Workplace Drug Testing Protection will be submitting the Health, 6701 Rockledge Drive, Room 6214, Programs (Oral Fluid), evaluation of hair following information collection request Bethesda, MD 20892, 301–594–7945, as an alternate matrix for drug testing, to the Office of Management and Budget kotliars@mail.nih.gov. and future board activities. The meeting (OMB) for review and approval in Name of Committee: Center for Scientific accordance with the Paperwork sradovich on DSK3GMQ082PROD with NOTICES will be closed to the public as Review Special Emphasis Panel; determined by the Assistant Secretary Reduction Act of 1995 (PRA). The Epidemiology of Environmental Exposures, information collection is published in Metabolism, and Kidney, Lung, and for Mental Health and Substance Use, SAMHSA, in accordance with 5 U.S.C. the Federal Register to obtain comments Infectious Disease. from the public and affected agencies. Date: December 11, 2017. 552b(c)(4) and (9)(B), and 5 U.S.C. App. Time: 1:00 p.m. to 4:00 p.m. 2, Section 10(d). DATES: Comments are encouraged and Agenda: To review and evaluate grant The web conference call-in number will be accepted (no later than January applications. and access code will only be available 16, 2018) to be assured of consideration. VerDate Sep<11>2014 19:58 Nov 14, 2017 Jkt 244001 PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 E:\FR\FM\15NON1.SGM 15NON1


Document Created: 2018-10-25 10:39:05
Document Modified: 2018-10-25 10:39:05
CategoryRegulatory Information
CollectionFederal Register
sudoc ClassAE 2.7:
GS 4.107:
AE 2.106:
PublisherOffice of the Federal Register, National Archives and Records Administration
SectionNotices
FR Citation82 FR 52935 
2025 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR